Emilly Caroline dos Santos Moraes

Emilly Caroline dos Santos Moraes

Auto-generated profile, based on publicly available information

Emilly Caroline dos Santos Moraes

Laboratory of Genetics and Molecular Biology, Department of Biology, Federal University of Maranhão, São Luis, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
MTMonique R. O. Trugilho
Monique R. O. Trugilho
IAIsaclaudia G. Azevedo-Quintanilha
Isaclaudia G. Azevedo-Quintanilha
JGJoão S. M. Gesto
João S. M. Gesto
EMEmilly Caroline S. Moraes
Emilly Caroline S. Moraes
SMSamuel C. Mandacaru
Samuel C. Mandacaru
PBPatricia Bozza
Patricia Bozza
Coronavirus disease 2019 (COVID-19) has affected over 400 million people worldwide, leading to 6 million deaths. Among the complex symptomatology of COVID-19, hypercoagulation and thrombosis have been described to directly contribute to lethality, pointing out platelets as an important SARS-CoV-2 target. In this work, we explored the platelet proteome of COVID-19 patients through a label-free shotgun proteomics approach to identify platelet responses to infection, as well as validation experiments in a larger patient cohort. Exclusively detected proteins (EPs) and differentially expressed proteins (DEPs) were identified in the proteomic dataset and thus classified into biological processes to map pathways correlated with pathogenesis. Significant changes in the expression of proteins related to platelet activation, cell death, and antiviral response through interferon type-I were found in all patients. Since the outcome of COVID-19 varies highly among individuals, we also performed a cross-comparison of proteins found in survivors and nonsurvivors. Proteins belonging to the translation pathway were strongly highlighted in the nonsurvivor group. Moreover, the SARS-CoV-2 genome was fully sequenced in platelets from five patients, indicating viral internalization and preprocessing, with CD147 as a potential entry route. In summary, platelets play a significant role in COVID-19 pathogenesis via platelet activation, antiviral response, and disease severity.

27 October 2023 in AMB Express
Verified
Journal Article
Open access
PDF file
MLMayara Lima
Mayara Lima
MCMeydson Benjamim Carvalho Corrêa
Meydson Benjamim Carvalho Corrêa
EMEmilly Caroline dos Santos Moraes
Emilly Caroline dos Santos Moraes
JOJaqueline das Dores Dias Oliveira
Jaqueline das Dores Dias Oliveira
PSPaula de Souza Santos
Paula de Souza Santos
LGLuiz Ricardo Goulart
Luiz Ricardo Goulart
The early diagnosis of leprosy serves as an important tool to reduce the incidence of this disease in the world. Phage display (PD) technology can be used for mapping new antigens to the development of immunodiagnostic platforms. Our objective was to identify peptides that mimic Mycobacterium leprae proteins as serological markers using phage display technology. The phages were obtained in the biopanning using negative and positive serum from household contacts and leprosy patients, respectively. Then, the peptides were synthesized and validated in silico and in vitro for detection of IgG from patients and contacts. To characterize the native protein of M. leprae, scFv antibodies were selected against the synthetic peptides by PD. The scFv binding protein was obtained by immunocapture and confirmed using mass spectrometry. We selected two phase-fused peptides, MPML12 and MPML14, which mimic the HSP60 protein from M. leprae. The peptides MPML12 and MPML14 obtained 100% and 92.85% positivity in lepromatous patients. MPML12 and MPM14 detect IgG, especially in the multibacillary forms. The MPML12 and MPML14 peptides had positivity of 11.1% and 16.6% in household contacts, respectively. There was no cross-reaction in patient’s samples with visceral leishmaniasis, tuberculosis and other mycobacteriosis for both peptides. Given these results and the easy obtainment of mimetic antigens, our peptides are promising markers for application in the diagnosis of leprosy, especially in endemic and hyperendemic regions.

14 August 2026 in Cytotherapy
Verified
Journal Article
Open access
JVJuliana Borges Vieira
Juliana Borges Vieira
MAMariana Alves Antunes Almeida
Mariana Alves Antunes Almeida
CSCarla Medeiros da Silva
Carla Medeiros da Silva
MCMarianna Ribeiro Cabral
Marianna Ribeiro Cabral
Renata Trabach SantosRenata Trabach Santos
Renata Trabach Santos
FCFernanda Ferreira Cruz
Fernanda Ferreira Cruz